| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.04. | Evotec SE Taps Dr. Ashiq H. Khan as EVP Global Head, Chief Commercial Officer | ||
| 01.04. | Genmab Appoints Margarida Duarte as GM, Europe and Emerging Markets | ||
| 01.04. | Orionis Biosciences Taps Dr. Giulio Draetta as Chief Strategy Officer | ||
| 31.03. | Bracco Imaging Upgrades Geneva Site | ||
| 31.03. | Exostar Taps Amy Hogan as Its First Chief Information Officer | ||
| 31.03. | Sanofi's Rezurock Approved in EU for Treatment of Chronic Graft-Versus-Host Disease | ||
| 31.03. | Samsung Biologics Acquires GSK Maryland Manufacturing Facility | ||
| 31.03. | Torqur, Lonza Partner to Advance Oncology Drug Candidate | ||
| 31.03. | Infinimmune, Merck Partner to Discover Human Antibody Therapeutics | ||
| 31.03. | Poxel Sells Kidney-Disease Drug Candidate to Scynexis for Up to $196 Million | ||
| 31.03. | Signadori Bio Taps Dr. Selwyn Ho as CEO | ||
| 30.03. | Shimadzu Scientific Instruments Opens New R&D Facility in San Francisco | ||
| 30.03. | Lunit and CellCarta to Collaborate on AI-Enabled Digital Pathology Workflows | ||
| 30.03. | Aurinia Pharmaceuticals Acquires Kezar Life Sciences | ||
| 30.03. | ImmuneOncia, Lonza Sign Manufacturing Pact for Late-Stage Antibody Program | ||
| 30.03. | UMass Chan, Caring Cross, Trenchant BioSystems Form Alliance to Develop Lower-Cost Gene-Therapy Manufacturing | ||
| 27.03. | AAPS Announces Plenary Speakers for 2026 National Biotechnology Conference | ||
| 27.03. | Biocon Names Shreehas Tambe CEO and Managing Director | ||
| 27.03. | Novartis Agrees to Acquire Excellergy | ||
| 27.03. | Merck Agrees to Acquire Terns for $6.7B | ||
| 27.03. | Schreiner MediPharm Develops Transparent Deep-Freeze Seal | ||
| 26.03. | Lunai Bioworks Acquires $20M in BBB Delivery Tech, CNS Alzheimer's Assets from Clemann Group | ||
| 26.03. | Ligand Pharmaceuticals Unveils Two New VPs of Investments, Business Development | ||
| 26.03. | Hoth Therapeutics Launches OpenClaw AI for Accelerating Drug Discovery | ||
| 26.03. | Lifecore Biomedical Inks Two New Agreements with Existing US Customer |